A systematic review and economic evaluation of the clinical effectiveness and cost effectiveness of aldosterone antagonists for postmyocardial infarction heart failure
McKenna C, Burch J, Suekarran, S, Walker, S, Bakhai A, Witte, K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S
Record ID 32010000168
English
Authors' recommendations:
Treatment with aldosterone antagonists such as eplerenone and spironolactone are likely to be highly cost-effective uses of NHS resources for the management of postmyocardial infarction heart failure. Further research is warranted on the relative benefits of one aldosterone antagonist over the other.
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1817
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Aldosterone
- Myocardial Infarction
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen’s Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.